ACTO Unveils Next-Gen LAICA™: The Premier AI Knowledge Assistant for Pharma Teams

On May 14, 2025, at the Veeva Commercial Summit in Boston, ACTO, a prominent technology partner of Veeva, unveiled the next generation of LAICA™ (Life Sciences AI Conversational Assistant), which is designed specifically for pharmaceutical field teams. This innovative AI-driven knowledge assistant promises to revolutionize the way field representatives interact with healthcare providers (HCPs).

Enhanced Conversational Capabilities

The latest iteration of LAICA is not just an incremental upgrade; it represents a significant leap in both intelligence and personalization. Field representatives, who often engage with healthcare professionals possessing extensive experience, will benefit from LAICA's ability to provide immediate, relevant information. Whether it’s answering a quick query or accessing detailed insights, LAICA is there to ensure that representatives can communicate with confidence and clarity.

Parth Khanna, CEO of ACTO, emphasized the transformative impact LAICA has had on how field teams access and utilize vital information. “When we launched LAICA three years ago, it marked the beginning of a new era in how reps work with essential knowledge. The AI space is ever-evolving, continually learning and adapting to provide more accurate, personalized answers,” he said.

Intuitive Support for Field Teams

Imagine a pharma representative who approaches a clinic with a healthcare provider who has more than 15 years of experience in a specific therapeutic area. LAICA can assist this representative even before they step into the clinic by delivering concise answers to last-minute questions, boosting their confidence and enhancing the quality of the interaction. This proactive approach signifies a shift in how technology supports field teams, making them more prepared and effective in their roles.

The innovative the new LAICA will integrate several pre-configured data sources and content hubs, which will facilitate faster and more accurate responses to on-site queries. Notable features include:

- Training content and clinical articles
- Real-time customer insights
- Market access, reimbursement, and prescribing information

This expanded “knowledge universe” enhances LAICA’s cognitive capabilities, allowing it to process complex prompts and deliver precise, compliant answers.

Emotional Intelligence Enhancement

In addition to cognitive improvements, LAICA's emotional intelligence has been refined. By utilizing data regarding each representative's experience and confidence level, LAICA tailors its responses to better suit the user's background. This personalized interaction means that LAICA can offer proactive suggestions that aid representatives in deepening their understanding of critical topics, ultimately leading to more meaningful discussions with healthcare professionals.

Lisa Dreher, Head of National Sales Training at Currax Pharmaceuticals, shared her enthusiasm: “Our goal is to empower field teams to engage in impactful, personalized conversations with healthcare representatives. LAICA plays a crucial role in this by providing quick, role-specific access to the essential knowledge they require, along with pertinent suggestions. This not only enhances pre-call planning but also elevates the quality of every interaction with HCPs.”

The Future of AI in Pharma

As ACTO moves forward, the company is committed to advancing LAICA to ensure it becomes an indispensable tool for field teams across the pharmaceutical industry. Attendees at the Veeva Commercial Summit can witness LAICA in action at ACTO’s booth on May 13-14, 2025.

For more information, visit ACTO's website or follow them on LinkedIn for the latest updates and news.

About ACTO

ACTO is an AI-driven Intelligent Field Excellence (IFE) platform dedicated to life sciences. It supports sales, marketing, and medical teams in enhancing customer engagement and brand performance by transforming field representatives into "Masters of Message". By doing so, ACTO enables biopharma companies to ensure that their representatives always convey the right messages to healthcare representatives while providing frontline managers with critical insights to continually enhance field effectiveness. The platform adheres to FDA regulations and is SOC 2 Type II certified, making it a trusted partner for smart field excellence in life sciences.

© 2025 ACTO Technologies, Inc. All rights reserved. All product names and services are trademarks of their respective owners.